Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: Exploring the implications of new data

Charles J. Ryan, Philip J. Saylor, Jason J. Everly, Oliver Sartor

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: Exploring the implications of new data'. Together they form a unique fingerprint.

Medicine & Life Sciences